Can estradiol (estrogen) patches cause psychiatric side effects?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Psychiatric Side Effects of Estradiol Patches

Estradiol patches can cause psychiatric side effects in some individuals, particularly mood changes including depression and anxiety, with effects varying based on individual sensitivity to hormonal fluctuations.

Potential Psychiatric Effects

Estradiol patches and other estrogen-based therapies may be associated with various psychiatric effects:

  • Mood changes: Research demonstrates that estradiol can affect mood in both positive and negative ways 1, 2
  • Depression risk: Studies show that withdrawal from estradiol can trigger depressive symptoms in susceptible individuals 1
  • Anxiety symptoms: Estrogen affects regions of the brain involved in anxiety regulation, including the hippocampus and amygdala 3

Mechanisms and Risk Factors

The relationship between estradiol and psychiatric symptoms appears to be mediated by several factors:

  • Individual sensitivity: Some individuals have heightened sensitivity to normal hormonal fluctuations 4
  • Genetic predisposition: Genetic variations in serotonin transporter genes, estrogen receptors, and other pathways influence individual sensitivity to hormone-related mood changes 4
  • Hormonal fluctuations: Rapid changes in estrogen levels appear more impactful on emotional state than consistently high levels 4
  • Prior psychiatric history: Women with a history of mood disorders may be more vulnerable to estrogen-related mood changes 4, 1

Clinical Evidence

The evidence regarding estradiol's psychiatric effects is mixed:

  • A randomized controlled trial found that transdermal estradiol was effective for treating depression in perimenopausal women, suggesting potential antidepressant effects 5
  • Another study demonstrated that withdrawal from estradiol triggered recurrence of depressive symptoms in women with past perimenopausal depression, indicating that estrogen fluctuations can affect mood 1
  • Research on hormone replacement therapy showed improvements in anxiety and depression symptoms in menopausal women after 3 months of treatment with 17β-estradiol 2

Clinical Implications and Monitoring

When prescribing estradiol patches, clinicians should:

  • Screen for psychiatric history: Particularly focus on history of depression, anxiety, or perimenopausal mood disorders
  • Monitor for mood changes: Regular assessment of mood symptoms during initiation and dose adjustments
  • Be aware of withdrawal effects: Tapering rather than abrupt discontinuation may be preferable in sensitive individuals 1
  • Consider transdermal administration: When mood symptoms are a primary concern, transdermal estrogen administration may be preferred 4

Special Considerations

  • Transgender patients: In transgender women using feminizing hormone therapy that includes estradiol, mood changes may occur as part of the treatment 6
  • Perimenopause: Women with a history of perimenopausal depression may be particularly vulnerable to mood effects from estradiol fluctuations 1
  • Comorbid conditions: Estradiol may help manage conditions that can be exacerbated cyclically, such as migraine, epilepsy, irritable bowel syndrome, and some psychiatric symptoms 6

Key Takeaways

  • The psychiatric effects of estradiol patches vary widely between individuals
  • Both beneficial and adverse psychiatric effects are possible
  • Genetic factors and prior psychiatric history influence susceptibility
  • Monitoring for mood changes is important when initiating or discontinuing estradiol therapy
  • Withdrawal from estradiol can trigger depressive symptoms in vulnerable individuals

References

Research

[The effects of hormone replacement therapy in menopause on symptoms of anxiety and depression].

Turk psikiyatri dergisi = Turkish journal of psychiatry, 2003

Research

A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006

Guideline

Premenstrual Dysphoric Disorder (PMDD) Pathophysiology and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.